Rapport Therapeutics brings in $150M Series B funding round

Rapport Therapeutics raised $150 million in a Series B round nearly six months after it launched.

Related Keywords

Massachusetts ,United States ,Arrivent Biopharma ,Raymond Kelleher ,James Healy ,Abraham Ceesay ,Fidelity Management Research Company ,Rapport Therapeutics ,Fidelity Management ,Research Company ,Goldman Sachs Asset Management ,Logos Capital ,Johnson Innovation ,Third Rock Ventures ,Cormorant Asset Management ,Massachusetts General Hospital ,Arkuda Therapeutics ,Expansion Therapeutics ,Garuda Therapeutics ,Atsena Therapeutics ,Karuna Therapeutics ,